Oseltamivir IR Pellets Manufacturer in India

Oseltamivir IR Pellets Manufacturer in India

Pharmaceutical-Grade Oseltamivir IR Pellets for Immediate-Release Oral Formulations

Oseltamivir IR Pellets are multiparticulate pharmaceutical formulations designed for immediate-release oral dosage applications. The product uses Oseltamivir phosphate as the active ingredient. Oseltamivir phosphate has the CAS Number 204255-11-8, molecular formula C₁₆H₃₁N₂O₈P, and molecular weight 410.40 g/mol.

SDP's pellet product portfolio lists Oseltamivir IR Pellets at 75% strength, providing a high-loading multiparticulate option for pharmaceutical formulation applications.

The immediate-release pellet format is designed to support rapid release of the active ingredient from the multiparticulate system. Final release performance depends on the pellet composition, manufacturing process, particle characteristics and applicable product specification.

Key Features

• Oseltamivir immediate-release pharmaceutical pellets
• 75% active ingredient strength
• Pharmaceutical-grade multiparticulate formulation
• Immediate-release formulation platform
• Suitable for oral dosage-form development
• Suitable for capsule-filling applications
• High active ingredient loading
• Product-specific quality parameters
• Formulation flexibility for pharmaceutical manufacturers
• Suitable for bulk pharmaceutical requirements

Product Information

Oseltamivir is commonly supplied as Oseltamivir phosphate, the phosphate salt of Oseltamivir. PubChem identifies Oseltamivir phosphate with CAS 204255-11-8, formula C₁₆H₃₁N₂O₈P, and molecular weight 410.40 g/mol.

The free-base form of Oseltamivir is chemically distinct, with CAS 196618-13-0, formula C₁₆H₂₈N₂O₄, and molecular weight 312.40 g/mol. For the pellet product, the applicable active ingredient identity should therefore be specified according to the actual raw material used.

Available Strength

Oseltamivir IR Pellets — 75%

The 75% strength is listed for Oseltamivir IR Pellets in the referenced pharmaceutical pellet product catalogue.

Applications

Oseltamivir IR Pellets can be considered for:

• Immediate-release oral formulation development
• Multiparticulate pharmaceutical formulations
• Capsule-filling applications
• Oral dosage-form development
• Pharmaceutical formulation development
• Commercial pharmaceutical manufacturing

Why Oseltamivir IR Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets: Designed for pharmaceutical formulation applications.
• 75% Strength: High active ingredient loading for formulation flexibility.
• Immediate-Release Format: Designed for immediate-release multiparticulate applications.
• Multiparticulate Platform: Suitable for pellet-based oral dosage-form development.
• Product-Specific Quality Control: Finished pellets can be evaluated against defined product specifications.
• Capsule-Filling Applications: Suitable for formulation approaches using multiparticulate capsules.
• Bulk Pharmaceutical Supply: Suitable for commercial formulation requirements.

Packaging & Supply

Oseltamivir IR Pellets can be supplied in suitable bulk packaging according to customer requirements. Strength, batch quantity, packaging configuration and applicable documentation can be specified according to the intended pharmaceutical formulation.

Get Bulk Quote via WhatsApp